Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1CNS 1

Conditions

Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasms 1Motor Activity 1Medulloblastoma 1Lymphoma 1Leukemia 1Infratentorial Neoplasms 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1Ataxia 1

Interventions

Psychiatric Rehabilitation 5Melphalan 5Cyclophosphamide 5Methylprednisolone 4Flow Cytometry 4Busulfan 4Early Intervention, Educational 3Antilymphocyte Serum 3Alemtuzumab 3fludarabine phosphate 2Radiotherapy 2Immunologic Techniques 2Filgrastim 2Azacitidine 2thymoglobulin 1tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1pembrolizumab 1neratinib 1ixabepilone 1fosphenytoin 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1bempegaldesleukin 1aldesleukin 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Control Groups × CNS × Clear all
NCT00498719 2020-12-31

Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer

M.D. Anderson Cancer Center

Unknown
30 enrolled
CNSLymphoidOther hematologic neoplasm

Attention Deficit Disorder with Hyperactivity, Brain Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡